All entries by this author

Missouri Lawyers Weekly Covers MND Exclusion from Sherrer Pelvic Mesh Trial

Jan 19th, 2016 | By
Mo lawyers weekly front page

MND, Jan 19, 2016 ~ This is the second article prepared by Missouri Lawyers Weekly on the issue of excluding Mesh News Desk from coverage of the  Sheerer pelvic mesh trial. The story says it all.  Thank you Missouri Lawyers Weekly for allowing me to republish it.   *Update on the case – The defense
[continue reading…]

Cisson $2 million Compensatory and Punitive Verdict against C.R. Bard Upheld by Appellate Court

Jan 18th, 2016 | By
judge mallet 200

Mesh News Desk, January 18, 2016 ~ The pelvic mesh trial against manufacturer C.R. Bard was the first bellwether case to be held in the newly formed multidistrict litigation in Charleston, West Virginia. Right out of the gate, Donna Cisson’s attorney, Henry Garrard, presented to the jury the Material Safety Data Sheet that accompanied the raw
[continue reading…]

Pelvic Mesh-Injured Women Plan April Rally in Charleston, WV

Jan 18th, 2016 | By
Mesh Awareness Movement in Charleston, WV, June 2015

Mesh News Desk, January 18, 2016 ~ Organizers of mesh-injured women want the public to know a rally is planned for Charleston, West Virginia on Monday, April 11, 2016. That is the date that 37 transvaginal mesh trials will be heard on the same day before U.S. District Court Judge Joseph Goodwin. .  The defendant
[continue reading…]

RICO Suit Accuses Boston Scientific of Fraud in Smuggling Defective Pelvic Mesh from China

Jan 15th, 2016 | By
Phillips Petroleum Marlex, ad on ebay

Mesh News Desk, January 15, 2016 ~ This week the Mostyn law firm of Houston filed a federal racketeering lawsuit against Boston Scientific, the transvaginal mesh manufacturer already the focus of thousands of pelvic mesh actions in federal court in West Virginia.   The charge – Boston Scientific (BSX) knowingly smuggled and used counterfeit material
[continue reading…]

Upcoming Pennsylvania Pelvic Mesh Trials Has J&J Motioning to Exclude Experts

Jan 14th, 2016 | By
Philadelphia Court of Common Pleas

MND, January 14, 2016 ~ A review of documents in two upcoming pelvic mesh trials, scheduled for this month and next, show defendant Ethicon, a subsidiary of Johnson & Johnson, filing motions to gut the Plaintiffs’ case. Carlino v. Ethicon, ~ January 25, 2016, Philadelphia.  Case No. 1306-03470, Philadelphia Court of Common Pleas. On or about
[continue reading…]

Biomedical Expert on Regulatory Parellels of Pelvic Mesh to Breast Implants, Federal Preemption and There’s No Medical Grade Mesh

Jan 13th, 2016 | By
hyman cropped

MND, January 13, 2016 ~ Dr.William A. Hyman, a Biomedical expert has been brought in as a consultant in some pelvic mesh cases.  Dr. Hyman compares FDA’s reclassification of POP (pelvic organ prolapse) mesh to class III as a parallel to breast implant reclassification.  It forced them off the market, but they came back after anecdotal data,
[continue reading…]

CDC Ending Comments on Opioid Use for Chronic Pain

Jan 12th, 2016 | By
chronic pain

Mesh News Desk, January 12, 2016 ~ Several months ago the Centers for Disease Control and Prevention (CDC) proposed guidelines for opioid prescribing for those suffering  from chronic pain and mesh pain.  Since then there have been 1,800 comments registered. Wednesday, January 13th, the CDC closes the comment period. With 259 million prescriptions written in
[continue reading…]

Mesh News Desk Denied Access to Sherrer Pelvic Mesh Trial in Kansas City

Jan 8th, 2016 | By
Solyx pelvic mesh by Boston Scientific

Mesh News Desk, January 7, 2016~ On Thursday, January 7, Mesh News Desk (MND), its editor and readers were denied access to the pool camera and coverage of the pelvic mesh trial of Eve Sherrer in Kansas City, Missouri. Sherrer v. Boston Scientific and C.R. Bard began December 2 but was interrupted for the holidays. It
[continue reading…]

Broadly Covers Transvaginal POP Mesh Issue with MND Input

Jan 7th, 2016 | By

Mesh News Desk, January 7, 2015 ~ Your editor, Jane Akre was interviewed for this January 5th story in “Broadly” a unit of the HBO show VICE. Read the story here.   Reporter Gabby Bess was seeking a comment on the new Food and Drug Administration rule that reclassifies mesh used for pelvic organ prolapse
[continue reading…]

FDA Rules To Reclassify POP Vaginal Mesh as High Risk!

Jan 4th, 2016 | By
Uphold, Boston Scientific, still on the market

January 4, 2016 ~ An expert panel convened by the U.S. Food and Drug Administration (FDA) decided in September 2011 that mesh used to treat pelvic organ prolapse (POP) should be reclassified as high risk from its moderate risk (Class II) status. Today, the FDA announced POP mesh would finally be reclassified as a high
[continue reading…]